Drug intelligence / Profile preview

alutard phleum pratense

Development stage
Phase 3
Lead developer
ALK Abelló
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

Alutard Phleum pratense is a standardized allergen extract derived from the pollen of Timothy grass (Phleum pratense). It is formulated as a depot preparation adsorbed to aluminium hydroxide and administered by subcutaneous injection for allergen-specific immunotherapy (SCIT) in patients with IgE-mediated allergy to Timothy grass pollen. The primary indication is the treatment of moderate to severe seasonal allergic rhinoconjunctivitis (hay fever), with or without conjunctivitis. The mechanism of action involves desensitizing the immune system to the specific allergen by modulating immune responses—specifically inhibiting recruitment of T-lymphocytes and eosinophils, shifting cytokine production from Th2 to Th1 profile, increasing IL-10 synthesis leading to T-cell anergy, and reducing histamine release from basophils. This results in reduced allergic symptoms upon exposure to Timothy grass pollen[2][5][9]. Alutard Phleum pratense has been shown in clinical trials to reduce symptoms and medication use in patients with severe hay fever[9].

Brand names
alutardalutard sq
Other names
phleum pratense allergen extracttimothy grass pollen extract
02

Targets

IL10 (Interleukin-10)

Beyond the preview

Go deeper on alutard phleum pratense.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alutard phleum pratense.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call